You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage III childhood small noncleaved cell lymphoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell

Completed
Has Results
  • AIDS-related Diffuse Large Cell Lymphoma
  • +8 more
  • Eldoret, Kenya
  • +1 more
Sep 12, 2022

NSCLC Trial in Beijing

Recruiting
  • NSCLC
    • Beijing, China
      Yuyan Wang
    Oct 10, 2023

    NSCLC Trial in Changsha (Sugemalimab and Chemotherapy)

    Recruiting
    • Carcinoma, Non-Small-Cell Lung
    • Sugemalimab and Chemotherapy
    • Changsha, China
      Hunan Cancer Hospital
    Jul 7, 2023

    Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage I Grade 1 Follicular Lymphoma, Ann Arbor Stage I Grade 2

    Active, not recruiting
    • Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma
    • +22 more
    • External Beam Radiation Therapy
    • Orbital Radiation
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 9, 2022

    Stage III NSCLC Trial (Toripalimab, JS004, Pemetrexed)

    Not yet recruiting
    • Stage III Non-small Cell Lung Cancer
    • (no location specified)
    Jun 3, 2023

    Omitting Clinical Target Volume in Radical Treatment of

    Not yet recruiting
    • Immunotherapy
    • +3 more
    • IMRT+adjuvant immunotherapy
    • (no location specified)
    Jun 9, 2023

    Stage III NSCLC, Surgery Trial in Guangzhou (Lorlatinib)

    Not yet recruiting
    • Stage III NSCLC
    • Surgery
    • Guangzhou, Guangdong, China
      Guangdong Provincial People's Hospital
    Feb 21, 2023

    Nonsmall Cell Lung Cancer, Nonsmall Cell Lung Cancer, Stage II, Nonsmall Cell Lung Cancer Stage III Trial in Tampa (Genomically

    Recruiting
    • Nonsmall Cell Lung Cancer
    • +3 more
    • Genomically Guided Radiation Therapy (RT)
    • Tampa, Florida
      Moffitt Cancer Center
    May 23, 2023

    NSCLC, EGFR Sensitive Mutation, Adjuvant Therapy Trial in Beijing, Nanjing, Shanghai (Befotertinib + Icotinib , Icotinib +

    Recruiting
    • Non-Small Cell Lung Cancer
    • +2 more
    • Befotertinib + Icotinib placebo
    • Icotinib + Befotertinib placebo
    • Beijing, China
    • +2 more
    Sep 20, 2023

    Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer, Stage II Lung Cancer Trial in Nashville (drug, biological,

    Not yet recruiting
    • Limited Stage Lung Small Cell Carcinoma
    • +3 more
    • Nashville, Tennessee
      Vanderbilt University/Ingram Cancer Center
    Nov 10, 2023

    Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Metastatic Lung Non-Small Cell Carcinoma Trial in Seattle

    Terminated
    Has Results
    • Hematopoietic and Lymphoid Cell Neoplasm
    • +12 more
    • Laboratory Biomarker Analysis
    • ROR1 CAR-specific Autologous T-Lymphocytes
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Aug 11, 2022

    NSCLC Stage III Trial in Shanghai (standar thoracic RT dose, decreased thoracic RT dose)

    Recruiting
    • Non-small Cell Lung Cancer Stage III
    • standar thoracic RT dose
    • decreased thoracic RT dose
    • Shanghai, Shanghai, China
      Ruijin Hospital, Shanghai jiaotong univestigy school of medicine
    Sep 27, 2022

    Acute Side Effects In Stage III NSCLC With Definitive CRT

    Completed
    • Non-small Cell Lung Cancer Stage III
      • Ankara, Turkey
        Ankara University Medicine School Radiation Oncology
      Aug 22, 2023

      Limited-stage Small Cell Lung Cancer (LS-SCLC) Trial in Jinan (Tifcemalimab injection, toripalimab injection, Placebo for

      Not yet recruiting
      • Limited-stage Small Cell Lung Cancer (LS-SCLC)
      • Tifcemalimab injection
      • +3 more
      • Jinan, Shandong, China
        Shandong Cancer Hospital & Institute
      Oct 18, 2023

      Stage III NSCLC Trial (18F FDG PET/CT, CT scan)

      Not yet recruiting
      • Stage III Non-small Cell Lung Cancer
      • 18F FDG PET/CT
      • CT scan
      • (no location specified)
      Oct 9, 2023

      Lung Cancer Stage III Trial (ctDNA)

      Not yet recruiting
      • Lung Cancer Stage III
      • ctDNA
      • (no location specified)
      Oct 26, 2023

      NSCLC Trial in Shanghai (SH-1028 tablets, Placebo SH-1028 tablets)

      Recruiting
      • Non-small Cell Lung Cancer
      • SH-1028 tablets
      • Placebo SH-1028 tablets
      • Shanghai, Shanghai, China
        Shanghai Pulmonary Hospital
      Oct 6, 2023

      Lung Cancer, Nonsmall Cell, Lung Cancer Stage III Trial (combination product, drug, procedure, radiation)

      Not yet recruiting
      • Lung Cancer, Nonsmall Cell
      • Lung Cancer Stage III
      • Nivolumab and Chemotherapy
      • +3 more
      • (no location specified)
      Aug 15, 2023

      Recurrent NSCLC, Stage IIIA NSCLC, Stage IIIB NSCLC Trial in Buffalo (therapeutic lymphadenectomy (TEMLA) and Stereotactic Body

      Completed
      • Recurrent Non-small Cell Lung Cancer
      • +3 more
      • therapeutic lymphadenectomy (TEMLA) and Stereotactic Body radiation therapy (SBRT)
      • quality-of-life assessment
      • Buffalo, New York
        Roswell Park Cancer Institute
      Jul 20, 2022

      NSCLC Stage III Trial (radiotherapy, Platinum-Based Drug, Immunotherapy)

      Not yet recruiting
      • Non-small Cell Lung Cancer Stage III
      • radiotherapy
      • +3 more
      • (no location specified)
      Sep 10, 2023

      Unresectable Non-Small Cell Lung Cancer (Stage III) in Canada

      Completed
      • Non-small Cell Lung Cancer
      • Calgary, Alberta, Canada
      • +4 more
      Jun 28, 2023

      Non Small Cell Lung Cancer Trial in Shanghai (CS1001 mAb, CS1001 )

      Active, not recruiting
      • Non Small Cell Lung Cancer
      • CS1001 monoclonal antibody
      • CS1001 placebo
      • Shanghai, Shanghai, China
        Shanghai Pulmonary Hospital
      Nov 8, 2022

      NSCLC Stage III Trial in Hefei (Envafolimab)

      Not yet recruiting
      • Non-small Cell Lung Cancer Stage III
      • Hefei, Anhui, China
        Anhui Provincial Cancer Hospital
      Jun 8, 2022

      Unresectable Melanoma, Metastatic Melanoma, Stage III NSCLC Trial in Louisville, New York (IOV-4001)

      Recruiting
      • Unresectable Melanoma
      • +3 more
      • IOV-4001
      • Louisville, Kentucky
      • +2 more
      Nov 21, 2022

      Stage III Non-small-cell Lung Cancer Trial in Foshan, Guangzhou (other, radiation, drug)

      Recruiting
      • Stage III Non-small-cell Lung Cancer
      • Neoadjuvant therapy
      • +4 more
      • Foshan, Guangdong, China
      • +2 more
      Oct 25, 2022